UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

The Lancet (British edition), 2008-11, Vol.372 (9653), p.1881-1893

2008

Volltextzugriff (PDF)

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

Antimicrobial Agents and Chemotherapy, 2009-07, Vol.53 (7), p.2852-2856

2009

Volltextzugriff (PDF)

Advances in antifungal therapy

Annual review of medicine, 2008-01, Vol.59 (1), p.361-379

2008

Volltextzugriff (PDF)

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

The New England journal of medicine, 1997-09, Vol.337 (11), p.734-739

1997

Volltextzugriff (PDF)

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

The New England journal of medicine, 1997-09, Vol.337 (11), p.725-733

1997

Volltextzugriff (PDF)

Effect of Low-, Moderate-, and High-Fat Meals on Raltegravir Pharmacokinetics

Journal of clinical pharmacology, 2011-03, Vol.51 (3), p.422-427

2011

Volltextzugriff (PDF)

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

JAMA : the journal of the American Medical Association, 1998-07, Vol.280 (1), p.35

1998

Volltextzugriff (PDF)

Effect of Telcagepant on Spontaneous Ischemia in Cardiovascular Patients in a Randomized Study

Headache, 2011-06, Vol.51 (6), p.954-960

2011

Volltextzugriff (PDF)

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine

AIDS (London), 2003-11, Vol.17 (16), p.2345-2349

2003

Volltextzugriff (PDF)

Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects

Platelets (Edinburgh), 2010, Vol.21 (3), p.191-198

2010

Volltextzugriff (PDF)

THE CALCITONIN GENE-RELATED PEPTIDE RECEPTOR ANTAGONIST TELCAGEPANT DOES NOT REDUCE EXERCISE TOLERANCE IN PATIENTS WITH EXERCISE INDUCED MYOCARDIAL ISCHEMIA

Journal of the American College of Cardiology, 2010-03, Vol.55 (10), p.A100.E939-A100.E939

2010

Volltextzugriff (PDF)

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

Annals of internal medicine, 2000-07, Vol.133 (1), p.35

2000

Volltextzugriff (PDF)

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Journal of Virology, 1996-12, Vol.70 (12), p.8270-8276

1996

Volltextzugriff (PDF)

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study) : a double-blind, randomised, placebo-controlled, test-of-concept trial. Commentary

The Lancet (British edition), 2008, Vol.372 (9653)

2008

Volltextzugriff (PDF)

Granulocyte-Macrophage Colony-Stimulating Factor Enhances Selective Effector Functions of Tissue-Derived Macrophages

Blood, 1988-08, Vol.72 (2), p.573-578

1988

Volltextzugriff (PDF)

Macrophage colony-stimulating factor production by murine and human keratinocytes. Enhancement by bacterial lipopolysaccharide

The Journal of immunology (1950), 1990-03, Vol.144 (6), p.2190

1990

Volltextzugriff (PDF)

Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men

Sleep (New York, N.Y.), 2013-02, Vol.36 (2), p.259-267

2013

Volltextzugriff (PDF)

Effect of Different Durations and Formulations of Diltiazem on the Single-Dose Pharmacokinetics of Midazolam: How Long Do We Go?

Journal of clinical pharmacology, 2011-11, Vol.51 (11), p.1561-1570

2011

Volltextzugriff (PDF)

Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

British journal of clinical pharmacology, 2009-05, Vol.67 (5), p.520-526

2009

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist

Journal of clinical pharmacology, 2009-10, Vol.49 (10), p.1228-1238

2009

Volltextzugriff (PDF)

Designing Global Development Programs

Therapeutic innovation & regulatory science, 1999, Vol.33 (2), p.353-356

Chodakewitz, Jeffrey

1999

Volltextzugriff (PDF)

Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels : Application to a clinical trial

AIDS research and human retroviruses, 1999-04, Vol.15 (6), p.499-508

1999

Volltextzugriff (PDF)

Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine

AIDS (London), 2000-09, Vol.14 (13), p.1973-1978

2000

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

Advances in antifungal therapy

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

Effect of Low-, Moderate-, and High-Fat Meals on Raltegravir Pharmacokinetics

Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up

Effect of Telcagepant on Spontaneous Ischemia in Cardiovascular Patients in a Randomized Study

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine

Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects

THE CALCITONIN GENE-RELATED PEPTIDE RECEPTOR ANTAGONIST TELCAGEPANT DOES NOT REDUCE EXERCISE TOLERANCE IN PATIENTS WITH EXERCISE INDUCED MYOCARDIAL ISCHEMIA

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study) : a double-blind, randomised, placebo-controlled, test-of-concept trial. Commentary

Granulocyte-Macrophage Colony-Stimulating Factor Enhances Selective Effector Functions of Tissue-Derived Macrophages

Macrophage colony-stimulating factor production by murine and human keratinocytes. Enhancement by bacterial lipopolysaccharide

Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

Effect of Different Durations and Formulations of Diltiazem on the Single-Dose Pharmacokinetics of Midazolam: How Long Do We Go?

Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects

Pharmacokinetics, Safety, and Tolerability of Phentermine in Healthy Participants Receiving Taranabant, a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist

Designing Global Development Programs

Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels : Application to a clinical trial

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals : two double-blind, randomised placebo-controlled phase I studies. Commentary

Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine

Suchergebnisse filtern